Johnson & Johnson seeks approval of diabetes pill

Associated Press Published: May 31, 2012

NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson said Thursday it filed for marketing approval to the Food and Drug Administration of its drug canagliflozin, a once-per-day pill intended to treat Type 2 diabetes.

Canagliflozin is one of Johnson & Johnson's most promising drug candidates. The company's Janssen division has the right to market the drug in North and South America, Europe, the Middle East, Africa, Australia, New Zealand, and some Asian countries.

Shares of Johnson & Johnson rose 35 cents to $62.56 in morning trading.

Trending Now


  1. 1
    10 Most Popular Wedding 'First Dance' Songs
  2. 2
    Psychologists Studied the Most Uptight States in America, and Found a Striking Pattern
  3. 3
    Facebook Post Saves Drowning Teen
  4. 4
    Saturday's front page of the New York Times sports section is simple: LeBron James and transactions
  5. 5
    The 19th-century health scare that told women to worry about "bicycle face"
+ show more